Keywords: myriad, advance, mpc-4505, usa-based, genetics, reported, new

Myriad to advance MPC-4505

Article | 26 April 2004

USA-based Myriad Genetics has reported new preclinical data for its MPC-4505, a highly selective neurokinin-1 receptor antagonist with potential utility ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing